论文部分内容阅读
目的:运用离子导入仪将活血通络、温经止痛的中药液导入患处治疗脑卒中后肩手综合征早期患者的疗效观察。方法:将符合纳入标准者86例,按照随机数字表法分为两组,治疗组43例,在常规综合康复法基础上同时运用现代离子导入仪导入活血通络、温经止痛的中药液于患肢治疗;对照组43例,给予常规综合康复疗法,疼痛严重者可口服美洛昔康片治疗。1周为1个疗程,4个疗程后比较两组上肢运动功能及疼痛等改善情况,采用Fugl-Meyer简化上肢运动功能评分(FMA)、视觉模拟评分法(VAS)及临床疗效情况。结果:治疗4个疗程后,治疗组患肢运动功能及关节疼痛、肿胀等改善明显优于对照组,两组比较,差异有统计学性意义(P<0.01)。结论:配合离子导入仪导入活血通经、温经止痛的中药液治疗脑卒中后肩手综合征的早期患者,可以有效改善上肢功能,减轻手指、腕部水肿,减轻肩关节疼痛,促进患者上肢功能、手指功能的康复,降低致残率。
OBJECTIVE: To introduce the Chinese medicine solution of Huoxuetongluo and Wenjing Analgesia into the affected area to treat the early stage shoulder-hand syndrome patients after stroke by iontophoresis. Methods: Eighty-six patients who met the inclusion criteria were divided into two groups according to the random number table method. The treatment group received 43 cases. On the basis of conventional comprehensive rehabilitation method, the modern iontophoresis instrument was used to introduce Huoxuetongluo, In the limb treatment; control group of 43 cases, given conventional comprehensive rehabilitation therapy, severe pain may be oral meloxicam tablets treatment. 1 week for 1 course of treatment. After 4 courses of treatment, the improvement of upper limbs’ motor function and pain were compared between two groups. Fugl-Meyer simplified upper extremity motor function score (FMA), visual analogue scale (VAS) and clinical efficacy were used. Results: After 4 courses of treatment, the improvement of limb motor function, joint pain and swelling in the treatment group was significantly better than that of the control group. There was significant difference between the two groups (P <0.01). Conclusion: The introduction of Huoxuetongjing and Wenjing analgesic Chinese medicine solution in the early stage of patients with shoulder-hand syndrome after stroke can effectively improve the function of the upper limbs, reduce the edema of fingers and wrists, relieve shoulder pain and promote the patients Upper extremity function, finger function rehabilitation, reduce the disability rate.